Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019

Pimentel‐Nunes, Pedro; Libânio, Diogo; Marcos‐Pinto, Ricardo; Areia, Miguel; Leja, Mārcis; Esposito, Gianluca; Garrido, Mónica; Ķikuste, Ilze; Mégraud, Françis; Matysiak‐Budnik, Tamara; Annibale, Bruno; Dumonceau, Jean‐Marc; Barros, Rita; Fléjou, Jean–François; Carneiro, Fátima; E. van Hooft, Jeanin; J. Kuipers, Ernst; Dinis‐Ribeiro, Mário

doi:10.1055/a-0859-1883

Public

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019

Published in Endoscopy • Mar 6, 2019

Authors:

Pedro Pimentel‐Nunes

Diogo Libânio

Ricardo Marcos‐Pinto

Abstract

Main Recommendations Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric adenocarcinoma. This underscores the importance of diagnosis and risk stratification for these patients. High definition endoscopy with chromoendoscopy (CE) is better than high definit...

Subject

Medicine

Atrophic gastritis

Chromoendoscopy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!